جست‌وجوی استاد و پژوهشگر

Hutan Ashrafianمشاهده پروفایل

استاد

• Artificial Intelligence in Medicine
• Metabolic Surgery
• Health Policy
• +۴ مورد دیگر

Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.

Deborah Foxمشاهده پروفایل

دانشیار

• Midwifery
• Maternal Health
• Technology in Healthcare
• +۷ مورد دیگر

Deborah Fox is Associate Professor in Midwifery at the University of Technology Sydney (UTS), Faculty of Health, and a core member of the Centre for Midwifery, Child and Family Health. She serves as Co-lead of the Maridulu Budyari Gumal SPHERE Maternal and Women's Clinical Theme and Chair of the National Publicly Funded Homebirth Consortium. In 2024, she received the Faculty of Health Dean's Academic Excellence Award for Research (Mid Career Researcher), following her 2021 award as Highest Performing Early Career Researcher from the School of Nursing and Midwifery. Her research focuses on optimizing physiological processes and positive experiences for women with complex pregnancies, with particular emphasis on the mediation of technology in midwifery practice. Current projects include evaluation of non-invasive fetal ECG beltless and wireless fetal monitoring in labor and birth, and examining the social, economic and environmental impacts of telemonitoring and telehealth in pregnancy and postpartum care. Dr. Fox's scholarly work demonstrates consistent focus on technology's role in maternity care, women's experiences of monitoring during labor, and innovative approaches to midwifery practice. Her recent publications show increasing emphasis on digital health solutions, AI applications in women's health, and pandemic impacts on maternal care systems globally. Faculty of Health Dean's Academic Excellence Award for Research (Mid Career Researcher) 2024 Highest Performing Early Career Researcher award from School of Nursing and Midwifery 2021 Editorial Board Member, Women and Birth journal Dr. Fox is actively involved in higher degree research supervision and has developed innovative teaching resources, including an Objective Structured Clinical Examination for perinatal mental healthcare. She is scheduled to spend three months as a Visiting Scholar at the University of Oxford in 2025.

• Affective Neuroscience
• Emotion Regulation
• Schizophrenia Spectrum Disorders
• +۴ مورد دیگر

Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.

Margaret Bublitzمشاهده پروفایل

دانشیار

• Perinatal Mental Health
• Integrated Behavioral Health
• Mindfulness-Based Interventions
• +۶ مورد دیگر

Margaret Bublitz is Associate Professor at Brown University with joint appointments in the Department of Psychiatry and Human Behavior , Department of Medicine , and Department of Obstetrics and Gynecology . She holds secondary appointments at the School of Public Health as Senior Investigator and Behavioral and Social Sciences faculty member. Dr. Bublitz earned her PhD in Clinical Psychology (2010) from the University of British Columbia, followed by postdoctoral training in Cardiovascular Behavioral Medicine at Brown Medical School. Her research focuses on: Psychological stress pathways to adverse perinatal outcomes Maternal childhood maltreatment effects on neurobiology Mindfulness interventions for hypertension and preterm birth prevention Her 15 most recent publications demonstrate expertise in perinatal mental health , sleep-disordered breathing , HPA axis regulation , and fetal neurodevelopment , with significant collaborations in neuroendocrinology and maternal-infant health disparities . Scientific recognition includes: 2024-2025 Global Fulbright Scholarship 2022 Brown Early Career Research Achievement Award Multiple NIH and foundation grants exceeding $6 million Bublitz leads NIH-funded projects examining mechanisms of mindfulness training (R01HL157288) and serves as mentor in the MORPHE Trial for digital maternal health innovations. She is a licensed psychologist and active member of Brown's Stress, Trauma and Resilience (STAR) Institute and Mindfulness Center .

• Maternal Fetal Medicine
• Ultrasound
• Preeclampsia
• +۳ مورد دیگر

Giuseppe Rizzo is a Full Professor at the Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome. His academic career focuses on Maternal Fetal Medicine, with expertise in ultrasound applications, fetal growth restriction, preeclampsia, and congenital anomalies. Research Interests : Delivery optimization, prematurity prediction, ultrasound diagnostics, and placental anomalies. Recent Publications : Over 15 high-impact studies in 2024-2025 on topics like umbilical cord abnormalities, cerebroplacental ratios, and gestational diabetes complications. Clinical Expertise : Prenatal counseling, Doppler ultrasound, and labor management protocols. Collaborations : Active in multicenter trials across Italy and Europe, with a focus on fetal neurosonology and high-fidelity obstetric simulation.

• Environmental Health
• Climate Change
• Public Health Equity
• +۵ مورد دیگر

Dr. Daniel Carrión is an Assistant Professor of Epidemiology at the Yale School of Public Health, Department of Environmental Health Sciences. His work bridges climate science , energy transitions , and health equity , focusing on structural inequality’s role in exposure and health disparities. Education: PhD in Environmental Health Sciences (Columbia University, 2019); MPH in Environmental Health Sciences (New York Medical College, 2011); BA in Environmental Studies (Ithaca College, 2008). His research examines how home and neighborhood environments serve as intervention points for climate and health equity . Recent studies include modeling heat vulnerability in U.S. housing, geospatial analysis of lead water lines, and clean cooking interventions in Ghana. Articles span climate change , air pollution , and social determinants , with methodological focus on exposure science and case-crossover designs . Scientific honors include: Senior Fellow, Agents of Change in Environmental Justice (2022) Fellow, New York Academy of Medicine (2022) Senior Fellow, Environmental Leadership Program (2019) He contributes to community service as a member of the New York State Minority Health Council (2016–present) and the International Society for Environmental Epidemiology (2018–present). His work integrates satellite data , machine learning , and policy evaluation to address energy insecurity , racial segregation , and climate justice .

E.I. Friedمشاهده پروفایل

دانشیار

• Clinical psychology
• Psychiatry
• Epidemiology
• +۶ مورد دیگر

Dr. Eiko Fried is an Associate Professor at Leiden University's Faculty of Social and Behavioural Sciences, where he works at the intersection of clinical psychology, psychiatry, epidemiology, methodology, and complexity science. His research focuses on improving psychological science through open science practices and innovative measurement approaches. PhD in clinical psychology, Free University of Berlin Postdoctoral training at KU Leuven and University of Amsterdam Promoted to Associate Professor at Leiden University in 2021 Key research areas include: Psychopathology measurement and classification Network analysis in mental health research Ecological momentary assessment (EMA) methodology Open science advocacy and implementation Dynamic systems modeling in psychology Transdiagnostic approaches to mental disorders Recent publications demonstrate expertise in: Symptom network analysis across disorders Improving depression measurement standards Transdiagnostic assessment protocols Mental health data integration challenges Psychological theory construction Methodological innovations in clinical research

Robert Frenchمشاهده پروفایل

پژوهشگر ارشد

• Educational Psychology
• Public Health
• Health Inequalities
• +۳ مورد دیگر

Dr. Robert French is a Senior Research Fellow at Cardiff University's School of Social Sciences. His work focuses on the intersection of health, education, and social policy, with a particular emphasis on data linkage methodologies to address disparities in healthcare and educational outcomes. He leads projects such as the ADR UK-funded initiative to establish frameworks for linking child health and education datasets in England and Wales. Key research interests include educational attainment dynamics, health inequalities among LGBTQ+ populations, and the impact of chronic conditions like diabetes on academic performance. His recent work explores factors influencing Special Educational Needs identification in Wales and the long-term outcomes of Graves' disease therapies. French's publications span epidemiology, public health, and social sciences, with methodological expertise in multilevel modeling and data integration. He collaborates with institutions like NHS Digital, the Royal College of Paediatrics and Child Health, and universities across Europe to advance evidence-based policymaking. His current projects include analyzing prescribing costs for diabetes treatments in Wales and examining cardiovascular risks linked to Graves' disease. French is also involved in public engagement, including workshops with Diabetes UK to inform ethical data usage frameworks. He holds leadership roles in multidisciplinary research teams and has secured grants from ADR UK and Wellcome Trust. His office is located at the University Hospital of Wales, Cardiff, reflecting his clinical and academic collaborations.

Kanwaljeet S. Anandمشاهده پروفایل

استاد

• Pediatric Pain and Stress Neurobiology
• Neonatal and Fetal Pain Assessment
• Biomarker Development
• +۳ مورد دیگر

Dr. Kanwaljeet S. Anand is a dual-appointed Professor of Pediatrics (Pediatric Critical Care) and Anesthesiology, Perioperative & Pain Medicine at Stanford University School of Medicine. As director of the Pain/Stress Neurobiology Lab and Jackson Vaughan Critical Care Research Fund, he serves as Editor-in-Chief of Pediatric Research and maintains active membership in Bio-X, MCHRI, and Wu Tsai Neurosciences Institute. Rhodes Scholar with D.Phil from University of Oxford Harvard postdoctoral fellowship and Boston Children's Hospital residency Founded Harmony Health Clinic - Arkansas' largest charitable medical-dental facility A translational researcher with 30+ years of impact, Dr. Anand established the first scientific framework for infant pain perception and developed novel pain assessment methodologies. Current research focuses on: Hair biomarker analysis for stress and social affiliation (cortisol/oxytocin) Machine learning systems for objective pain detection in non-verbal infants Biopsychosocial interventions for stress reduction in disadvantaged youth Neurotoxicity mechanisms of sedatives in developing brains Global NICU opioid usage patterns through the NeoOpioid Consortium His work has yielded over 260 publications and significant advances in: Pediatric pain management protocols Neonatal stress biomarker development Critical care neurobiology insights Community health initiatives AI-driven clinical decision support systems Scientific Recognition 9th Annual 'In Praise of Medicine' Public Address, Erasmus University (2014) Nightingale Excellence Award (2016) Honorary Doctorate from University of Örebro (2019) NIH SBIB-H82 Study Section Chair (2018) Multiple IASP and American Pain Society awards Swedish Academy of Medicine's Nils Rosén von Rosenstein Award (2009) St. Jude Endowed Chairholder (2010) As mentor to Med Scholar Anjali Gupta and advisor to numerous professional bodies, Dr. Anand maintains active clinical leadership in Pediatric Intensive Care while advancing computational approaches to pain detection through collaborations with Stanford's AI researchers.

• Maternal-Fetal Medicine
• Cardiovascular Disease in Pregnancy
• Hypertension in Pregnancy
• +۳ مورد دیگر

Dr. Annalies Denoble is an Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine. She specializes in maternal-fetal medicine, focusing on high-risk pregnancies, particularly those complicated by cardiovascular disease. Her research addresses gaps in understanding maternal heart disease, hypertension, and vaccine safety during pregnancy. Education: MD and MSc in Clinical Research, University of Michigan Medical School (2014) Bachelor of Arts in French Studies, Duke University (2008) Research Interests: Her work centers on cardiovascular complications in pregnancy, including hypertension, heart failure, and congenital heart disease. She collaborates with Yale's multi-disciplinary Pregnancy Heart Team to optimize care for patients with cardiac conditions. Her studies also investigate vaccine safety, preeclampsia, and maternal mortality reduction strategies. Recent Research Trends: Her publications highlight late-onset postpartum hypertension, vaccine safety in pregnancy, and hypertension progression during and after pregnancy. She emphasizes extending postpartum care and improving risk prediction models for adverse cardiac events. Awards: Recognized as a 'Top Doctor' in Yale Ob/Gyn Physicians for 2025. Collaborations & Clinics: Dr. Denoble works with the Pregnancy Heart Team and Yale Medicine's Maternal-Fetal Medicine unit. She sees patients at locations in New Haven, New London, and Waterbury, CT.

A.T. Charlie Johnsonمشاهده پروفایل

استاد

• Condensed Matter Physics
• Nanotechnology
• Nanomaterials
• +۴ مورد دیگر

A.T. Charlie Johnson serves as the Rebecca W. Bushnell Professor of Physics and Astronomy at the University of Pennsylvania's School of Arts & Sciences, where he has been a standing faculty member since 1994. His research program focuses on nanoscale systems and has established him as a leading figure in condensed matter physics, earning recognition from major scientific societies. His educational foundation includes: Ph.D. in Physics from Harvard University (1990) B.S. in Physics from Stanford University (1984) Professor Johnson's research centers on the development and application of atomic-layer nanomaterials, particularly graphene and transition metal dichalcogenides , for fundamental studies of transport phenomena and practical biosensor applications. His group employs advanced nanofabrication techniques at Penn's Singh Center for Nanotechnology to create devices that leverage biological molecules for chemical recognition in disease diagnosis, security screening, and environmental monitoring. This work bridges condensed matter physics with biomedical engineering , yielding innovative solutions for real-world detection challenges. Analysis of his 2023-2025 publications reveals three dominant research thrusts: (1) scalable graphene-based biosensor development for medical diagnostics, (2) exploration of quantum phenomena like Klein tunneling in novel nanoelectromechanical systems, and (3) interdisciplinary applications spanning oncology, planetary science, and fetal medicine. His work consistently emphasizes materials synthesis , device integration , and practical translation of nanoscale phenomena. His scientific contributions have been recognized with prestigious honors: Defense Science Study Group Fellow (2018-2019) Fellow of the American Association for the Advancement of Science (2017) Fellow of the American Physical Society (2011) Lindback Foundation Award for Distinguished Teaching (2003) David and Lucille Packard Foundation Fellowship (1994-1999) As an educator, Professor Johnson has mentored numerous graduate students and postdoctoral researchers, with notable alumni like Michael Biercuk (founder of Q-CTRL). His research has been supported through significant leadership roles including Director of the Nano/Bio Interface Center (2014-2017) and Packard Fellowship funding, enabling sustained innovation in nanotechnology. His group actively collaborates across disciplines to advance both fundamental understanding and practical applications of nanomaterials. Based at the Singh Center for Nanotechnology, Johnson leads a dynamic research team utilizing state-of-the-art facilities for nanofabrication and characterization. His laboratory maintains strong campus collaborations through secondary appointments in Electrical and Systems Engineering and Materials Science and Engineering, fostering an interdisciplinary environment for developing next-generation nanoscale devices.

• Epidemiology of Birth Defects
• Gene-Environment Interactions in Perinatal Health
• Nutrition and Reproductive Outcomes
• +۴ مورد دیگر

Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.

Caroline Samerمشاهده پروفایل

دانشیار

• Pharmacogenomics
• Precision Medicine
• Clinical Pharmacology
• +۳ مورد دیگر

Caroline Samer is an Associate Professor at the University of Geneva (UNIGE) Faculty of Medicine and serves as the Head of the Division of Clinical Pharmacology and Toxicology at the Hôpitaux Universitaires de Genève (HUG) . She also acts as the Delegate to the Dean's Office for Data Issues since July 2023. Medical Degree (2001), PhD in Pharmacogenomics, Postdoctoral Fellowship in Molecular Pharmacology (Sydney) President of the Swiss Society for Clinical Pharmacology and Toxicology (SSPTC) and Swiss Society of Pharmacology and Toxicology (SSPT) Vice-President of Swissethics and the Geneva Research Ethics Committee (CCER) Her research focuses on personalizing drug therapy through pharmacogenomics and precision medicine , emphasizing gene-environment-disease interactions and omic technologies . Key themes include drug interactions , pharmacokinetic modeling , and therapeutic information . Recent publications highlight her work in pharmacogenomics , drug safety , and clinical pharmacology , with a focus on opioids , antiaggregants , and drug metabolism . Her collaborations span oncopediatrics , internal medicine , medical informatics , and pharmaceutical sciences . She leads the Samer-Daali Research Group , which integrates in vitro , in vivo , and in silico models to advance personalized therapy . Her work is supported by institutional affiliations with the Faculty Center of Translational Investigation in Biomarkers and CIOMS .

• Neonatology
• Pediatrics
• Body Composition
• +۵ مورد دیگر

Overview Catherine O'Neill Buck is an Assistant Professor in the Department of Pediatrics, Division of Neonatal-Perinatal Medicine at Yale School of Medicine. She is a neonatologist and clinical researcher focused on maternal metabolic health during pregnancy and its influence on infant growth, body composition, and neurodevelopment. Her work bridges clinical care and translational research, with a particular emphasis on preterm infants and obesity prevention. Education & Training MD: University of Connecticut School of Medicine BS: University of Connecticut (Molecular/Cell Biology and Spanish) Pediatric Residency: University of Texas Southwestern Medical School (2015) Neonatal-Perinatal Medicine Fellowship: Brown University/Women and Infants Hospital (2019) MHS (Clinical Investigation): Yale School of Medicine (2025) Research Focus Dr. Buck's research investigates how maternal metabolic conditions (e.g., diabetes) and early neonatal nutrition affect preterm and term infants' growth trajectories, adiposity, and long-term cardiometabolic health. Key areas include: Adipokine and metabolite profiling in newborns Ultrasound-based body composition assessment in preterm infants Optimizing nutritional protocols for preterm growth Impact of maternal diabetes on neonatal morbidities Clinical Trial Principal Investigator for the trial Preventing Obesity in Preterm Infants (HIC ID 2000031084), exploring strategies to mitigate obesity risks in preterm populations. Labs/Teams Leads the Yale Neonatal NOuRISH Team , focusing on nutritional and metabolic interventions for neonates.

• Clinical Psychology
• Community Psychology
• Health Services Research
• +۷ مورد دیگر

Joy S. Kaufman is a Professor in the Department of Psychiatry at Yale School of Medicine. She serves as Deputy Chair for Career Development, Director of the Yale Consultation Center, and Director of YaleEVAL. Her work focuses on large-scale evaluations of health service delivery systems in under-resourced communities, emphasizing community-based participatory research and stakeholder training. Education: PhD in Clinical and Community Psychology, DePaul University (1994) Postdoctoral Fellow, Yale University (1993) MA in Psychology, DePaul University BA in Psychology, Assumption College Dr. Kaufman specializes in health equity , trauma exposure in children , and program evaluation . Her research bridges public health , social justice , and behavioral health policy through rigorous methodologies. Recent publications highlight her work on opioid use disorder in obstetric care , perinatal substance use reporting , and system-level mental health evaluations . She employs latent class analysis and CBPR frameworks to address disparities. Scientific Awards: Fellow, American Psychological Association Fellow, Society for Community Research and Action Gold Medal, Substance Abuse and Mental Health Services Administration Exemplary Evaluation, American Evaluation Association As principal investigator, she has secured funding from the National Institute of Justice , PCORI , and Connecticut state agencies . Her leadership extends to training community members in evaluation methods and developing trauma-informed healthcare systems .